Clinical Trial Update: Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule [Phase 4]

View source ↗

Summary

A Phase 4 study by GlaxoSmithKline evaluated how long immune responses persist after a two-dose (0 and 12 months) schedule of their inactivated hepatitis A vacc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Havrix (hepatitis A vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A | Phase 4 | Status: COMPLETED | Results posted: 2010-03-08